Fagron is involved in the development and production of personalized medicines and pharmaceutical products. Self-described as having a presence in EMEA, North America, and Latin America.

Fagron NV, a pharmaceutical compounding company, provides personalized medicine care to hospitals, pharmacies, clinics, and patients. The company also innovates concepts, vehicles, and formulations for pharmaceutical compounding. In addition, it supplies raw materials, utensils and equipment, semi-finished products, vehicles, and sterile and non-sterile compounded medicines. Further, the company offers education and training program to prescribers and pharmacists through the Fagron Academy. It has operations in Latin America, North America, Europe, the Middle East, and Africa. The company was formerly known as Arseus NV and changed its name to Fagron NV in January 2015. Fagron NV was founded in 1990 and is based in Nazareth, Belgium.

COM:FAGRON

Fagron

Last Close

18.28

22/11 16:35

Market Cap

1.34B

Beta: -

Volume Today

51.43K

Avg: -

locale

market

industry

website

ipo date

peer of

competitor of

Metrics